Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Lifestyle coaching can help improve blood pressure control in Black adults with hypertension

Culturally tailored lifestyle coaching can help Black adults with hypertension improve their blood pressure control, new Kaiser Permanente research shows.

18 May 2022

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

Children's Hospital Colorado (Children's Colorado) is the first hospital in the world to implant the newly FDA-approved G-Armor Stent. Although the stent is designed to be used in the smallest of patients, it was first implanted in a Colorado father of two.

18 May 2022

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

Nearly 18 months after getting covid-19 and spending weeks in the hospital, Terry Bell struggles with hanging up his shirts and pants after doing the laundry.

18 May 2022

Early valve replacement surgery could benefit patients with aortic stenosis

Valve replacement heart surgery should be performed earlier than conventionally thought for people with aortic stenosis – according to new research from the University of East Anglia.

18 May 2022

Time-restricted eating may reduce cardiovascular risk among older breast cancer survivors

Older breast cancer survivors with cardiometabolic risk factors who restricted food intake to eight hours during the weekday, followed by 16 hours of fasting, lowered their risk of cardiovascular disease (CVD) after a few weeks, according to a new research letter publishing today in JACC: CardioOncology.

17 May 2022

Allergic asthma, allergies may be associated with the risk of cardiovascular diseases

When most people think of cardiovascular diseases (CVD), risk factors such as high blood pressure, high cholesterol, obesity, and diabetes likely come to mind.

16 May 2022

Hispanic people with chest pain may experience unwarranted treatment delays in the ER

Hispanic people who went to the emergency room reporting chest pain waited longer than non-Hispanic people to be treated, admitted to the hospital or discharged from the ER, according to preliminary research to be presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2022.

13 May 2022

A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

The Agency for Science, Technology and Research's Genome Institute of Singapore and Bioinformatics Institute, as well as the National Heart Centre Singapore, National University of Singapore, and pharmaceutical company Novo Nordisk have signed an agreement to study the mechanisms underlying cardiovascular disease progression - especially the condition called heart failure with preserved ejection fraction (HFpEF).

13 May 2022

New therapeutic approach for cardiac repair after a heart attack

Following a heart attack, the human body is incapable of repairing lost tissue due to the heart's inability to generate new muscle.

12 May 2022

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Researchers at the University of Maryland School of Medicine (UMSOM) have been collaborating on an extensive heart registry that includes student-athletes in the Big Ten athletic conference, to learn more about cardiac issues in those who have recovered from a COVID-19 infection.

11 May 2022

Death rates for cardiovascular diseases vary among subgroups of Asian Americans

In a large, retrospective study covering data from the last two decades, death rates for cardiovascular diseases in the U.S. varied among people from various Asian ethnicity subgroups, with death rate trends that stagnated in some subgroups and increased in others, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, a peer-reviewed journal of the American Heart Association.

10 May 2022

Combined use of traditional cigarettes and e-cigarettes does not reduce cardiovascular disease risk

People who use both traditional (combustible) cigarettes and e-cigarettes do not reduce their risk of cardiovascular disease compared to people who exclusively use traditional cigarettes, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

6 May 2022

ACNAP-EuroHeartCare Congress 2022: Latest evidence on how to optimize cardiovascular care

Discover how patients with heart disease can live well, be healthy, and live longer at ACNAP-EuroHeartCare Congress 2022, a scientific congress of the European Society of Cardiology (ESC).

6 May 2022

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

Immune checkpoint inhibitors are widely used to treat a variety of cancers; however, one serious side effect is the onset of type 1 diabetes.

6 May 2022

High-performing age-stratified machine-learning models for the prediction of the severity of COVID-19 progression

The current study aims to use sophisticated machine learning models that stratify patient data by age group to predict disease progression in almost 7,000 patients studied in community hospital settings.

4 May 2022

Educational attainment associated with better health in Black women

One of the best things Black women can do for their health may be to get a college education, according to results of a national analysis.

3 May 2022

$6 million grant to fund research investigating the role of immune system in heart failure

A new grant for researchers at Washington University School of Medicine in St. Louis will fund research investigating the role of the immune system in heart failure. Finding ways to harness beneficial immune cells could lead to new therapies that encourage the heart to heal after injuries.

2 May 2022

Obesity progression may contribute to the economic burden of the disease, studies suggest

Obesity is known to approximately double healthcare costs in the US compared to those with a healthy weight.

2 May 2022

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

In a recent randomized clinical trial of hospitalized patients with COVID-19 and cardio-metabolic risk factors, the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin did not significantly reduce patients' risk of organ failure, kidney problems, or death compared with placebo, although numerically fewer participants treated with dapagliflozin experienced these outcomes. The findings are published in CJASN.

29 Apr 2022

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Researchers examined the characteristics and outcomes of COVID-19 in immunocompromised patients.

29 Apr 2022

Heart Failure News and Research

Further Reading

Lifestyle coaching can help improve blood pressure control in Black adults with hypertension

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

Early valve replacement surgery could benefit patients with aortic stenosis

Time-restricted eating may reduce cardiovascular risk among older breast cancer survivors

Allergic asthma, allergies may be associated with the risk of cardiovascular diseases

Hispanic people with chest pain may experience unwarranted treatment delays in the ER

A*STAR, NHCS, NUS, and Novo Nordisk partner to study the mechanisms underlying heart failure

New therapeutic approach for cardiac repair after a heart attack

UMSOM researchers participate in Big Ten health registry to learn about cardiac issues in athletes recovering from COVID-19

Death rates for cardiovascular diseases vary among subgroups of Asian Americans

Combined use of traditional cigarettes and e-cigarettes does not reduce cardiovascular disease risk

ACNAP-EuroHeartCare Congress 2022: Latest evidence on how to optimize cardiovascular care

Stem cell therapy prevents type 1 diabetes induced by anti-cancer drugs

High-performing age-stratified machine-learning models for the prediction of the severity of COVID-19 progression

Educational attainment associated with better health in Black women

$6 million grant to fund research investigating the role of immune system in heart failure

Obesity progression may contribute to the economic burden of the disease, studies suggest

Dapagliflozin did not reduce risks in patients hospitalized with COVID-19

Clinical characteristics of immunocompromised patients infected with the SARS-CoV-2 Omicron variant

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News